A novel tumor mutation-related long non-coding RNA signature for predicting overall survival and immunotherapy response in lung adenocarcinoma

A novel tumor mutation-related long non-coding RNA signature for predicting overall survival and immunotherapy response in lung adenocarcinoma

Background: Immunotherapy has changed the treatment landscape for lung cancer. This study aims to construct a tumor mutation-related model that combines long non-coding RNA (lncRNA) expression levels and tumor mutation levels in tumor genomes to detect the possibilities of the lncRNA signature as an...

Full description

Bibliographic Details
Main Authors: Wenjie Chen, Chen Liao, Xudong Xiang, Heng Li, Qiang Wu, Wen Li, Qianli Ma, Nan Chen, Benchao Chen, Gaofeng Li
Format: Article
Language:English
Published: Elsevier 2024-04-01
Series:Heliyon
Subjects:
Tumor mutation
Immune checkpoint inhibitor
Prognosis
Long non-coding RNA
Lung adenocarcinoma
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844024047017

Internet

http://www.sciencedirect.com/science/article/pii/S2405844024047017

Similar Items